Share issue 2017

IMPORTANT NOTICE

You are about to view a web page containing information and documentation that are not intended for release, publication or distribution, directly or indirectly, in or into the United States of America, Canada, Australia, New Zealand, Hong Kong, Japan (other than in relation to existing shareholders and to such extent that is given under the provisions regarding the so called “small number private placement” under Article 2, Paragraph 3, Item 2, Sub-item (ha) of the Financial Instruments and Exchange Act of Japan), Singapore or South Africa or in another country where the offer or distribution of the documentation violates with applicable laws or regulations or requires that a further prospectus must be presented, registered or another measure undertaken beyond what is required by Swedish law. By clicking "Yes, I accept" you accept the terms of use below.

The offer according to the terms set out in the documentation is not directed to people whose participation in the offer requires additional prospectuses, registration or measures other than those pursuant to Swedish law. The prospectus and other documents connected to the prospectus may not be distributed in any country in which the distribution or the offer requires measures as outlined above or are contrary to the regulations in such countries. The subscription rights, interim shares and shares encompassed by the offer according to the prospectus have not been registered and will not be registered in accordance with the United States Securities Act from 1933 in its current wording or any provincial legislation in Canada, Australia, New Zealand, Hong Kong, Japan (other than in relation to existing shareholders and to such extent that is given under the provisions regarding the so called “small number private placement” under Article 2, Paragraph 3, Item 2, Sub-item (ha) of the Financial Instruments and Exchange Act of Japan), Singapore or South Africa and may not be offered or sold, directly or indirectly, to persons domiciled in any of these countries or for the account of such a person or another country where the offer requires further action than what is required by Swedish law. Application to acquire shares contrary to the above may be viewed as invalid and consequently ignored.

No public offering of the shares is being made in Japan. The shares have not been and will not be registered under Article 4, Paragraph 1 of the Financial Instruments and Exchange Act of Japan, on the grounds that the rights issue to shareholders in Japan made pursuant to the documentation qualifies as a “small number private placement” under Article 2, Paragraph 3, Item 2, Sub-item (ha) of the Financial Instruments and Exchange Act of Japan.

Disputes arising from the offer and the documentation (including the contents of the prospectus and thereto connected legal matters) shall be determined exclusively by a Swedish Court. Swedish law is exclusively applicable on the prospectus and the offer in accordance to the prospectus.

In order to be eligible to view the information on the following web page, you shall be deemed, by accessing the following web page, to have confirmed and represented that (i) you have read and accepted the terms and restrictions set out above, and (ii) you are not located in the United States of America, Canada, Australia, New Zealand, Hong Kong, Japan (other than in relation to existing shareholders and to such extent that is given under the provisions regarding the so called “small number private placements” under Article 2, Paragraph 3, Item 2, Sub-item (ha) of the Financial Instruments and Exchange Act of Japan), Singapore or South Africa or another jurisdiction where the offer requires further action than what is required by Swedish law. 

Yes, I confirm

No, I do not confirm

  • Login
Close
VIGMED AB,
Garnisonsgatan 10
SE-254 66 Helsingborg,
Sweden
+46 42-280090
LOADEMAIL[info]DOMAIN[vigmed.com]
to top
Share issue